|
|
|
|
| LEADER |
01819nmm a2200373 u 4500 |
| 001 |
EB002003330 |
| 003 |
EBX01000000000000001166231 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
211020 ||| eng |
| 100 |
1 |
|
|a Eroglu, Imdat
|
| 245 |
0 |
0 |
|a Potential of "long-COVID" in triggering chronic co-pathologies
|h Elektronische Ressource
|c an interview with Imdat Eroglu
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2021, 2021
|
| 300 |
|
|
|a 1 streaming audio file (15 min.))
|
| 505 |
0 |
|
|a Contents: Mounting evidence implicating "long-COVID" as a trigger for chronic pathologies -- Range of long-term pathologies already linked to long-COVID -- SARS-CoV-2-induced interference of gut physiology and tryptophan biochemistry leading to widespread inflammation across multiple organs -- Cellular mechanisms implicated in triggering co-pathologies: SARS-CoV-2 impact on the gut-brain axis -- Possible preventive efforts for long-COVID-induced chronic pathologies, and symptoms management and treatments
|
| 653 |
|
|
|a Gastrointestinal system / Diseases
|
| 653 |
|
|
|a Gastrointestinal Microbiome
|
| 653 |
|
|
|a Commorbity
|
| 653 |
|
|
|a COVID-19 (Disease) / Treatment
|
| 653 |
|
|
|a Inflammation
|
| 653 |
|
|
|a COVID-19 / complications
|
| 653 |
|
|
|a SARS-CoV-2
|
| 653 |
|
|
|a Brain
|
| 653 |
|
|
|a COVID-19 (Disease) / Health aspects
|
| 653 |
|
|
|a COVID-19 / rehabilitation
|
| 653 |
|
|
|a COVID-19 / physiopathology
|
| 653 |
|
|
|a Tryptophan
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Research and clinical interviews
|
| 500 |
|
|
|a Audio interview. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/4768
|x Verlag
|z Streaming video file
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/1060
|3 Series
|
| 082 |
0 |
|
|a 570
|